Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd has declared the voting result of its Annual General Meeting, with all four resolutions passed with requisite majority. The resolutions include the adoption of annual accounts, re-appointment of a director, increase in authorized share capital, and approval for issuance of convertible warrants. The voting results are available on the company's website.

Chandra Bhagat Pharma Ltd

The 23rd Annual General Meeting (AGM) of Chandra Bhagat Pharma Ltd was held on September 1, 2026, where the company's financial statements for the year ended March 31, 2026, were adopted, and the reappointment of a director and the issuance of convertible warrants were approved.

Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd has issued a corrigendum to its AGM notice, providing an updated link to a compliance certificate for a proposed preferential issue of convertible warrants.

Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd has announced its 23rd Annual General Meeting scheduled for September 1, 2026, along with the submission of its annual report for the financial year 2025-26. The meeting will be held at the company's registered office in Mumbai, and the agenda includes the adoption of annual accounts, re-appointment of a director, and an increase in the authorized share capital.

Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd has submitted its Annual Report for the financial year 2025-26, along with the notice for its 23rd Annual General Meeting scheduled on September 1st, 2026. The report includes the company's financial statements, auditor's report, and other relevant information.

Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd has announced the outcome of its Board Meeting, where it approved the increase in authorized share capital, issue of convertible warrants, and other agenda items. The company also announced the details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 05/08/2026 to consider and approve fund raising through preferential issue.

Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd has announced that it is not required to submit a Corporate Governance Report for the quarter ended June 30, 2026, as it falls under an exemption in SEBI's Listing Obligation and Disclosure Requirements Regulation, 2015.